We are live on ! Find out more
AVXL icon

Anavex Life Sciences
AVXL

62 hedge funds and large institutions have $41.5M invested in Anavex Life Sciences in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 13

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

2% more funds holding

Funds holding: 61 → 62 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.08% less ownership

Funds ownership: 24.88% → 23.8% (-1.1%)

24% less capital invested

Capital invested by funds: $54.7M → $41.5M (-$13.2M)

87% less call options, than puts

Call options by funds: $593K | Put options by funds: $4.65M

Holders
62
Holders Change
+1
Holders Change %
+1.64%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
22
Reduced
13
Closed
5
Calls
$593K
Puts
$4.65M
Net Calls
-$4.05M
Net Calls Change
+$1.46M

Top Buyers

1
BlackRock
BlackRock
New York
+$404K
2
SFG
SNS Financial Group
Minnesota
+$311K
3
Group One Trading
Group One Trading
Illinois
+$266K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$172K
5
VF
Virtu Financial
New York
+$110K

Top Sellers

1
PWAM
Park West Asset Management
California
-$1.91M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$333K
3
Deutsche Bank
Deutsche Bank
Germany
-$262K
4
MWNA
Marshall Wace North America
New York
-$176K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$127K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
51
Ameritas Investment Partners
Nebraska
$11K – – –
IWM
52
IHT Wealth Management
Illinois
$11K – – –
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
$8K -$333K -75,000 -97%
QCG
54
Quadrant Capital Group
Ohio
$7K – – –
Citigroup
55
Citigroup
New York
$5K -$13.6K -3,059 -73%
AIM
56
Advantage Investment Management
Iowa
$4K – – –
ASN
57
Advisory Services Network
Georgia
$2K – – –
SPIA
58
Steward Partners Investment Advisory
New York
$2K +$2.22K +500 New
MAM
59
Meeder Asset Management
Ohio
$1K -$2.06K -464 -71%
BL
60
Balentine LLC
Georgia
$1K – – –
TIM
61
Tortoise Investment Management
New York
$1K – – –
MWNA
62
Marshall Wace North America
New York
– -$176K -35,141 Closed
Squarepoint
63
Squarepoint
New York
– -$77K -14,400 Closed
AIM
64
Acrospire Investment Management
Illinois
– -$15K -2,796 Closed
Creative Planning
65
Creative Planning
Kansas
– -$12K -2,280 Closed
WAS
66
Winch Advisory Services
Wisconsin
– -$1K -250 Closed
1 2
3

AVXL Hedge Fund Activity: Q3 2017 in Review

62 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2017, worth a combined $41.5M — down 24% from $54.7M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new AVXL positions and 5 closed out — a net gain of 2 holders — while 22 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $404K. The largest seller was Park West Asset Management, cutting an estimated $1.91M.

  • 62 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2017, up from 61 in Q2 2017.
  • Funds reported $41.5M of Anavex Life Sciences stock for Q3 2017, down 24% quarter-over-quarter.
  • 7 funds opened new Anavex Life Sciences positions in Q3 2017 and 5 closed out, a net change of +2 holders.
  • The largest Anavex Life Sciences buyer in Q3 2017 was BlackRock, an estimated $404K added.
  • The largest Anavex Life Sciences seller in Q3 2017 was Park West Asset Management, an estimated $1.91M sold.

Based on aggregated 13F filings for Q3 2017.